The Latest SPAC News and Rumors: September 19, 2022
by Marlena Haddad on 2022-09-19 at 11:36am

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  DWAC fails to pay proxy solicitors, and Ocean Biomedical discovers new therapy that can potentially kill cancerous cells


Trump SPAC fails to pay proxy firm despite tough hunt for votes, Financial Times reports

Executives behind a SPAC Digital World Acquisition Corp (NASDAQ:DWAC) that plans to take Donald Trump’s media business public have failed to pay their proxy solicitors, The Financial Times reported on Saturday.

Digital World Acquisition Corp, set up by Patrick Orlando, has not paid Saratoga Proxy Consulting for its work helping to rally shareholders, report said, citing people familiar with the matter.

READ

Ocean Biomedical discovers new therapy that can potentially kill cancerous cells

Ocean Biomedical and Aesther Healthcare Acquisition Corp. announced the discovery of a therapy that could potentially kill glioblastoma and melanoma cells – two types of cancerous cells – and block the spread of these cells to the lungs.

The company discovered antibodies that can target both CHI3L1, a regulator of a series of cancer-causing pathways, and ICPI, immune checkpoint inhibitors.

The Providence-based biopharma company recently announced it has entered a merger agreement with special purpose acquisition company Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA), which is expected to be complete by the end of 2022. Ocean Biomedical will then become a subsidiary of Aesther Healthcare Acquisition Corp. and the combined company will be renamed Ocean Biomedical Inc.

READ

 

Recent Posts
by Kristi Marvin on 2024-05-04 at 11:45am

Terms Tracker for the Week Ending May 3, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The big news this week was that SPACs finally had a new IPO price with Churchill Capital Corp. IX’s $250 million offering on Thursday.  SPACs...

by Nicholas Alan Clayton on 2024-05-03 at 3:56pm

Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...

by Nicholas Alan Clayton on 2024-05-03 at 8:02am

At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...

by Nicholas Alan Clayton on 2024-05-02 at 3:03pm

Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...

by Nicholas Alan Clayton on 2024-05-02 at 10:56am

Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved